Results 151 to 160 of about 4,918,610 (234)

Natural language processing (NLP)-assisted assessment of neurologic severity and functional outcomes in factor Xa inhibitor-related intracranial hemorrhages. [PDF]

Front Neurol
Sutton SS, Magagnoli J, Pittman R, Cummings TH, Ofori-Asenso R.   +4 more
europepmc   +1 more source

Factor Xa inhibitor, edoxaban ameliorates renal injury after subtotal nephrectomy by reducing epithelial-mesenchymal transition and inflammatory response. [PDF]

Physiol Rep, 2022
Fang L, Ohashi K, Ogawa H, Otaka N, Kawanishi H, Takikawa T, Ozaki Y, Takahara K, Tatsumi M, Takefuji M, Murohara T, Ouchi N.   +11 more
europepmc   +1 more source

Difficulties Detecting Clinically Relevant Factor Xa Inhibitor Levels Prior to Reversal With Andexanet Alfa for Intracranial Hemorrhage. [PDF]

Neurohospitalist, 2022
Davis SEB, Dehne KA, Rubinos CA, Lau WK, Northam KA.   +4 more
europepmc   +1 more source

Impact of code stroke on door-to-andexanet administration time for factor Xa inhibitor-associated intracranial hemorrhage: a single-center retrospective study. [PDF]

Front Neurol
Tanaka K, Imazu E, Ishihara T, Koge J, Hashimoto T, Matsumura K, Fujiwara E, Suyama K, Muto J, Hayakawa M, Yasuda A, Nakahara I, Koyama H, Kira JI, Hirose Y, Matsumoto S.   +15 more
europepmc   +1 more source

Use and outcomes of prothrombin complex concentrate for factor Xa inhibitor-associated bleeding. [PDF]

Thromb Res, 2021
Frank AK, Ganesan P, Thompson A, Fang MC.   +3 more
europepmc   +1 more source

Real-world clinical decision of andexanet alfa administration for intracranial hemorrhage during anticoagulant therapy using factor Xa inhibitor. [PDF]

J Crit Care Med (Targu Mures)
Yamashiro S, Harada K, Izumi S, Morikawa Y, Ikemoto T, Kameno K, Goto T, Ohmori Y, Kaji M, Mukasa A.   +9 more
europepmc   +1 more source

ROS-sensitive liposomal co-delivery of photosensitizer, factor Xa inhibitor, and PD-L1 blockade enhances photodynamic immunotherapy. [PDF]

Theranostics
Mai Y, Chen Y, Li C, Wang T, Ding S, Zhang H, Lin H, Jiang L, Yuan C, Zhou X, Huang M, Xu P.   +11 more
europepmc   +1 more source

Andexanet alfa vs standard of care for factor Xa inhibitor-induced intracranial hemorrhage-a systematic review and meta-analysis. [PDF]

Res Pract Thromb Haemost
Xiang AJ, Sadafi SL, Principato R, Shaikh A, Nowrouzi M, Eshaghpour A, Li A, Crowther M.   +7 more
europepmc   +1 more source

A meta-analysis of andexanet alfa and prothrombin complex concentrate in the treatment of factor Xa inhibitor-related major bleeding. [PDF]

Res Pract Thromb Haemost, 2021
Jaspers T, Shudofsky K, Huisman MV, Meijer K, Khorsand N.   +4 more
europepmc   +1 more source

Incidence and outcomes of major bleeding among first-time oral factor Xa inhibitor users: multinational observational cohort studies. [PDF]

Res Pract Thromb Haemost
Cohen AT, Welsh RC, Leentjens J, Canbay A, Choudhuri S, Er C, Chai-Adisaksopha C, Dover DC, Smits E, Mamza JB, Gao H, Zhang R, Randhawa AK, Beekman W, Scherg F, Palacios B, Godfrey G, Lang E, Arenillas J, Coleman CI, AXIOM Research Group.   +20 more
europepmc   +1 more source